INmune Bio (INMB) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
INmune Bio (INMB) has outperformed Instil Bio (TIL) over the past year, losing 5.1% versus a loss of 62.9%. Over five years, INMB leads with a -90.0% price change compared with -98.1% for TIL. INmune Bio is the larger company by market cap ($51.6 million vs $46.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INMB | TIL |
|---|---|---|
| Share price | $1.86 | $6.90 |
| Market cap | $51.62M | $46.80M |
| 1-day change | -0.53% | +0.22% |
| YTD return | +19.23% | -37.27% |
| 1-year return | -5.10% | -62.86% |
| 5-year return | -90.01% | -98.07% |
| EPS (TTM) | $-0.67 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.60 | $21.98 |
| 52-week low | $1.09 | $5.67 |
| Distance from 52-week high | -28.46% | -68.61% |
| Average volume | 421.24K | 12.01K |
| Shares outstanding | 27.75M | 6.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INMB has outperformed TIL by 57.8 percentage points over the past year.
INMB vs TIL FAQ
Which is bigger, INmune Bio or Instil Bio?
INmune Bio (INMB) is larger, with a market capitalization of $51.62M compared with $46.80M for Instil Bio (TIL).
Which stock has performed better over the past year, INMB or TIL?
INMB returned -5.10% over the past 12 months, compared with -62.86% for TIL (price return, excluding dividends). Past performance does not predict future results.
Are INmune Bio and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.